See what others are discussing and join the conversation.
Enhertu for HER2-Low and -Ultralow Metastatic Breast Cancer Dec 12, 2024 Dr. Aditya Bardia discusses Enhertu for metastatic hormone receptor-positive, HER2-low and -ultralow breast cancer and explains those terms. At the 2024 San Antonio Breast Cancer Symposium, Dr. Aditya Bardia, director of the Breast Oncology Program…
It looks like you're new here. Sign in or register to get started.
Kia Lee, a virtual support group facilitator and breast cancer survivor, shares the insight and wisdom that came with her diagnosis and treatment.
Our Community director shares how many people discover that cancer can change the people around them - and what they need from those relationships.
Our Community Director reflects on conversations with members of our young with MBC support group about giving themselves time and grace.
Browse our merchandise
We'd love to hear it.